JP2014501730A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501730A5 JP2014501730A5 JP2013541148A JP2013541148A JP2014501730A5 JP 2014501730 A5 JP2014501730 A5 JP 2014501730A5 JP 2013541148 A JP2013541148 A JP 2013541148A JP 2013541148 A JP2013541148 A JP 2013541148A JP 2014501730 A5 JP2014501730 A5 JP 2014501730A5
- Authority
- JP
- Japan
- Prior art keywords
- sulfate
- cyclic
- group
- optionally substituted
- monosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC1(C(C*)OC(*)C(*)C1*)OC(C(C1*)*=C)OC(C*)C1OC1OC(C*)C(*)CC1* Chemical compound CC1(C(C*)OC(*)C(*)C1*)OC(C(C1*)*=C)OC(C*)C1OC1OC(C*)C(*)CC1* 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41882610P | 2010-12-01 | 2010-12-01 | |
| US61/418,826 | 2010-12-01 | ||
| PCT/AU2011/001550 WO2012071611A1 (en) | 2010-12-01 | 2011-11-29 | Histone inhibition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016105792A Division JP6142039B2 (ja) | 2010-12-01 | 2016-05-27 | ヒストン阻害 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014501730A JP2014501730A (ja) | 2014-01-23 |
| JP2014501730A5 true JP2014501730A5 (enExample) | 2014-08-21 |
Family
ID=46171086
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013541148A Pending JP2014501730A (ja) | 2010-12-01 | 2011-11-29 | ヒストン阻害 |
| JP2016105792A Active JP6142039B2 (ja) | 2010-12-01 | 2016-05-27 | ヒストン阻害 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016105792A Active JP6142039B2 (ja) | 2010-12-01 | 2016-05-27 | ヒストン阻害 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9226939B2 (enExample) |
| EP (1) | EP2646037B1 (enExample) |
| JP (2) | JP2014501730A (enExample) |
| KR (1) | KR101956335B1 (enExample) |
| CN (1) | CN103402526B (enExample) |
| AU (1) | AU2011335881B2 (enExample) |
| BR (1) | BR112013013544B1 (enExample) |
| CA (1) | CA2819642C (enExample) |
| DK (1) | DK2646037T3 (enExample) |
| ES (1) | ES2710857T3 (enExample) |
| HU (1) | HUE043546T2 (enExample) |
| IL (1) | IL226667A (enExample) |
| NZ (1) | NZ611316A (enExample) |
| SG (1) | SG190438A1 (enExample) |
| WO (1) | WO2012071611A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3105593B2 (ja) | 1991-10-18 | 2000-11-06 | 東海パルプ株式会社 | パルパー制御装置 |
| WO2018165656A1 (en) | 2017-03-10 | 2018-09-13 | The University Of North Carolina At Chapel Hill | Short-acting heparin-based anticoagulant compounds and methods |
| US11993627B2 (en) | 2017-07-03 | 2024-05-28 | The University Of North Carolina At Chapel Hill | Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides |
| US11865137B2 (en) | 2017-11-03 | 2024-01-09 | The University Of North Carolina At Chapel Hill | Sulfated oligosaccharides having anti-inflammatory activity |
| US11628179B2 (en) * | 2017-12-15 | 2023-04-18 | The Australian National University | Compounds for treating and preventing extracellular histone mediated pathologies |
| WO2019246264A1 (en) * | 2018-06-20 | 2019-12-26 | The University Of North Carolina At Chapel Hill | Cell protective methods and compositions |
| WO2020033824A1 (en) * | 2018-08-09 | 2020-02-13 | University Of Vermont And State Agricultural College | Inhibitors of acute severe inflammatory conditions |
| CA3130405A1 (en) * | 2019-02-25 | 2020-09-03 | The Australian National University | Compounds for treating and preventing net associated complications |
| WO2021097345A1 (en) | 2019-11-13 | 2021-05-20 | The University Of North Carolina At Chapel Hill | Heparan sulfate (hs) oligosaccharides effect in liver ischemia reperfusion injury |
| WO2022116981A1 (zh) * | 2020-12-01 | 2022-06-09 | 远大医药（中国）有限公司 | 一种聚阴离子纤维二糖苷类化合物的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847338A (en) * | 1985-03-28 | 1989-07-11 | University Of Iowa Research Foundation | Low molecular weight heparin fragments as inhibitors of complement activation |
| DK505488D0 (da) * | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | Middel og anvendelse af samme |
| US5583121A (en) | 1994-01-12 | 1996-12-10 | Michigan State University | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
| DE69514059T2 (de) | 1994-09-21 | 2000-05-25 | Allrad No. 19 Pty Ltd., Canberra | Eine elektrostatische Niederschlagsvorrichtung |
| AUPN261895A0 (en) | 1995-04-28 | 1995-05-18 | Australian National University, The | Preparation and use of sulfated oligosaccharides |
| WO1999004826A1 (en) | 1997-07-24 | 1999-02-04 | The Australian National University | Method for detection of fibrin clots |
| ITMI20021294A1 (it) * | 2002-06-12 | 2003-12-12 | Inalco Spa | Polisaccaridi batterici o-solfatati e loro uso |
| US20050282775A1 (en) | 2004-06-16 | 2005-12-22 | Paringenix, Inc. | Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome |
| US7468358B2 (en) * | 2004-06-16 | 2008-12-23 | Paringenix, Inc. | Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome |
| WO2006015171A2 (en) * | 2004-07-28 | 2006-02-09 | The Texas A & M University System | Use of glycosoaminoglycans for the prevention and treatment of sepsis |
| PT1877105E (pt) | 2005-04-29 | 2013-11-11 | Univ Australian | Método para formar uma composição radioativa injetável de partículas radioativas encapsuladas em carbono |
| EP1747785A1 (en) * | 2005-07-28 | 2007-01-31 | Istituto Clinico Humanitas | Cyclodextrins for blood detoxification |
| WO2007062403A2 (en) | 2005-11-28 | 2007-05-31 | Vernon D Rowe | Compositions useful for reducing nephrotoxicity and methods of use thereof |
| WO2007095688A1 (en) | 2006-02-23 | 2007-08-30 | The Australian National University | Methods for increasing the number of circulating cells |
| GB2450087A (en) * | 2007-06-11 | 2008-12-17 | Diosamine Dev Corp | Use of sulphated saccharides in the treatment of inflammatory and/or auto-immune diseases |
| EP2209485B1 (en) | 2007-11-06 | 2016-03-30 | Oklahoma Medical Research Foundation | Extracellular histones as biomarkers for prognosis and molecular targets for therapy |
| JP5645085B2 (ja) | 2008-04-24 | 2014-12-24 | ジ オーストラリアン ナショナル ユニバーシティー | マクロ分子を放射性標識化するための方法 |
| JP2011256111A (ja) * | 2008-10-03 | 2011-12-22 | Hayashibara Biochem Lab Inc | 敗血症の予防及び治療剤 |
-
2011
- 2011-11-29 DK DK11845528.6T patent/DK2646037T3/en active
- 2011-11-29 NZ NZ611316A patent/NZ611316A/en unknown
- 2011-11-29 ES ES11845528T patent/ES2710857T3/es active Active
- 2011-11-29 AU AU2011335881A patent/AU2011335881B2/en active Active
- 2011-11-29 CA CA2819642A patent/CA2819642C/en active Active
- 2011-11-29 EP EP11845528.6A patent/EP2646037B1/en active Active
- 2011-11-29 KR KR1020137016013A patent/KR101956335B1/ko active Active
- 2011-11-29 HU HUE11845528A patent/HUE043546T2/hu unknown
- 2011-11-29 US US13/990,031 patent/US9226939B2/en active Active
- 2011-11-29 WO PCT/AU2011/001550 patent/WO2012071611A1/en not_active Ceased
- 2011-11-29 BR BR112013013544-1A patent/BR112013013544B1/pt active IP Right Grant
- 2011-11-29 JP JP2013541148A patent/JP2014501730A/ja active Pending
- 2011-11-29 SG SG2013041579A patent/SG190438A1/en unknown
- 2011-11-29 CN CN201180066031.1A patent/CN103402526B/zh active Active
-
2013
- 2013-05-30 IL IL226667A patent/IL226667A/en active IP Right Grant
-
2016
- 2016-05-27 JP JP2016105792A patent/JP6142039B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016193917A5 (enExample) | ||
| EP2841109B1 (en) | Prodrugs of hydroxyl-comprising drugs | |
| Zhang et al. | Designing polymers with sugar-based advantages for bioactive delivery applications | |
| JP7128368B2 (ja) | セルロースアセテート及びセルロースアセテート組成物 | |
| ES2948660T3 (es) | Profármacos de gemcitabina | |
| JP2013501100A5 (enExample) | ||
| JP2017222712A5 (enExample) | ||
| JP2012512175A5 (enExample) | ||
| JP2012017342A5 (enExample) | ||
| BR112014013890A8 (pt) | formulação em pó seco de derivado de azol para inalação | |
| JP2017523777A5 (enExample) | ||
| JP2016537027A5 (enExample) | ||
| WO2017177149A3 (en) | Methods and compositions for car t cell therapy | |
| JP2013544242A5 (enExample) | ||
| JP2017509718A5 (enExample) | ||
| RU2015134583A (ru) | Фармацевтические композиции, содержащие доноры нитроксила | |
| JP2014513141A5 (enExample) | ||
| AU2024203637A1 (en) | Formulations of phosphoramidate derivatives of nucleoside drugs | |
| EP2964343B1 (de) | Carbosilanhaltiger feuerlöschschaum | |
| JP2013525414A5 (enExample) | ||
| JP2018515479A5 (enExample) | ||
| NZ592775A (en) | Octenidine composition | |
| JP2010508289A5 (enExample) | ||
| JP2014516627A5 (enExample) | ||
| PE20181925A1 (es) | Composiciones antineoplasicas |